pdufa.bio
CalendarReadoutsDevicesDecisionsApprovals/yrTrial oddsLearnResearchMethodology
Home › Readouts › December 2027

December 2027 clinical-trial readouts

trial-readout estimates for December 2027, each row linked to its primary source. Readout dates are estimated primary-completion windows from ClinicalTrials.gov and shift.
← November 2027
42 readouts
RARE · Dec 2027 (est.)
Triheptanoin — Medium-chain Acyl-CoA Dehydrogenase Deficiency
RNAC · Dec 2027 (est.)
Decartes-08 — Childhood-onset Systemic Lupus Erythematous
AKTS · Dec 2027 (est.)
AKY-1189 — Urothelial Carcinoma Bladder
ASND · Dec 2027 (est.)
TransCon CNP — Achondroplasia
ARWR · Dec 2027 (est.)
Plozasiran — Asthma
ANVS · Dec 2027 (est.)
buntanetap/posiphen — Early Alzheimers Disease
ANTX · Dec 2027 (est.)
Epetraborole — Mycobacterium Abscessus Infection
ALLO · Dec 2027 (est.)
Fludarabine — Large B-cell Lymphoma
ADAG · Dec 2027 (est.)
ADG106 — HER2-negative Breast Cancer
WVE · Dec 2027 (est.)
WVE-210201 — Overweight and Obesity
VSTM · Dec 2027 (est.)
avutometinib — Endometrioid Cancer
TLX · Dec 2027 (est.)
177Lu-TLX591 — Metastatic Castration-resistant Prostate Cancer
TAK · Dec 2027 (est.)
Tislelizumab — Minimal Residual Disease
STRO · Dec 2027 (est.)
Luveltamab tazevibulin — Head and Neck Squamous Cell Carcinoma HNSCC
SMMT · Dec 2027 (est.)
Ivonescimab — Extensive Stage Lung Small Cell Cancer
RVMD · Dec 2027 (est.)
RMC-6236 — NSCLC (Non-small Cell Lung Cancer)
RADX · Dec 2027 (est.)
RAD101 — Castration-Resistant Prostate Cancer (CRPC)
RGNX · Dec 2027 (est.)
Ranibizumab — Diabetic Macular Edema
BCTX · Dec 2027 (est.)
SV-BR-1-GM — Breast Cancer
BPTH · Dec 2027 (est.)
BP1001 in combination with Ventoclax plus decitabine — Acute Myeloid Leukemia (AML)
CANF · Dec 2027 (est.)
Piclidenoson — Plaque Psoriasis
DNLI · Dec 2027 (est.)
Tividenofusp Alfa — Mucopolysaccharidosis II
GOSS · Dec 2027 (est.)
Seralutinib — Pulmonary Arterial Hypertension
IMVT · Dec 2027 (est.)
IMVT-1402 — Generalized Myasthenia Gravis
INTS · Dec 2027 (est.)
INT230-6 — Sarcoma,Soft Tissue
JNJ · Dec 2027 (est.)
Apathy — Parkinson Disease
KURA · Dec 2027 (est.)
Ziftomenib — Gastrointestinal Stromal Tumor (GIST)
KYMR · Dec 2027 (est.)
KT-621 — Eosinophilic Asthma
LEGN · Dec 2027 (est.)
LCAR-B38M CAR-T Cell — Gastric Cancer
LLY · Dec 2027 (est.)
Mirikizumab — Crohn's Disease
MPLT · Dec 2027 (est.)
ML-007C-MA — Psychosis Associated With Alzheimer's Disease
NERV · Dec 2027 (est.)
Roluperidone — Negative Symptoms of Schizophrenia
NTLA · Dec 2027 (est.)
NTLA-2002 — Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
NUVL · Dec 2027 (est.)
Neladalkib — Locally Advanced Solid Tumor
OTLK · Dec 2027 (est.)
bevacizumab — Age-Related Macular Degeneration
PCVX · Dec 2027 (est.)
31-valent pneumococcal conjugate vaccine — Pneumococcal Vaccines
QGEN · Dec 2027 (est.)
INCB161734 — Parkinson Disease
QURE · Dec 2027 (est.)
AMT-191 — Fabry Disease
RIGL · Dec 2027 (est.)
Fostamatinib Disodium — Pancreatic Ductal Adenocarcinoma (PDAC)
PYXS · Dec 2027 (est.)
PYX-201 — Advanced Solid Tumors
SNDX · Dec 2027 (est.)
Revumenib — Acute Myeloid Leukemia
BPTH · Dec 2027 (est.)
BP1001 in combination with Ventoclax plus decitabine — Poliomyelitis
Looking for an approval probability for these? We deliberately don't publish one — here's why, and what we show instead (verified history + base rates).